WO2009083520A3 - Compositions orales liquides de florfenicol diluables dans l'eau de boisson - Google Patents

Compositions orales liquides de florfenicol diluables dans l'eau de boisson Download PDF

Info

Publication number
WO2009083520A3
WO2009083520A3 PCT/EP2008/068127 EP2008068127W WO2009083520A3 WO 2009083520 A3 WO2009083520 A3 WO 2009083520A3 EP 2008068127 W EP2008068127 W EP 2008068127W WO 2009083520 A3 WO2009083520 A3 WO 2009083520A3
Authority
WO
WIPO (PCT)
Prior art keywords
diluted
drinking water
liquid oral
florfenicol
compositions
Prior art date
Application number
PCT/EP2008/068127
Other languages
English (en)
Other versions
WO2009083520A2 (fr
Inventor
Sandrine Lacoste
Original Assignee
Ceva Sante Animale
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ceva Sante Animale filed Critical Ceva Sante Animale
Publication of WO2009083520A2 publication Critical patent/WO2009083520A2/fr
Publication of WO2009083520A3 publication Critical patent/WO2009083520A3/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/74—Synthetic polymeric materials
    • A61K31/785—Polymers containing nitrogen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

La présente invention a pour objet une composition orale liquide à forte concentration en florfénicol, diluable et miscible dans l'eau de boisson ayant une stabilité améliorée au cours du temps, ainsi qu'une composition buvable de florfénicol destinée au traitement des infections respiratoires et/ou digestives des animaux non humains.
PCT/EP2008/068127 2007-12-21 2008-12-21 Compositions orales liquides de florfenicol diluables dans l'eau de boisson WO2009083520A2 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0709197A FR2925335B1 (fr) 2007-12-21 2007-12-21 Compositions orales liquides de florfenicol diluables dans l'eau de boisson
FR07/09197 2007-12-21

Publications (2)

Publication Number Publication Date
WO2009083520A2 WO2009083520A2 (fr) 2009-07-09
WO2009083520A3 true WO2009083520A3 (fr) 2009-12-03

Family

ID=39764250

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/EP2008/068127 WO2009083520A2 (fr) 2007-12-21 2008-12-21 Compositions orales liquides de florfenicol diluables dans l'eau de boisson

Country Status (2)

Country Link
FR (1) FR2925335B1 (fr)
WO (1) WO2009083520A2 (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI1002023A2 (pt) * 2010-03-01 2011-10-25 Nanocore Biotecnologia S A forma farmacêutica sólida de dissolução rápida para tratamento de infecções bacterianas
CN114010594B (zh) * 2021-09-30 2023-01-03 枣庄学院 一种氟苯尼考自微乳

Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014340A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition injectable comprenant du florfenicol comme principe actif
WO2004014341A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif
KR20050102309A (ko) * 2004-04-21 2005-10-26 대한뉴팜(주) 플로르페니콜을 유효성분으로 하는 주사제 조성물
WO2006067138A2 (fr) * 2004-12-21 2006-06-29 Intervet International B.V. Composition veterinaire injectable
KR20060105826A (ko) * 2005-04-04 2006-10-11 주식회사 고려비엔피 동물약품용 약제학적 조성물
CN101152169A (zh) * 2007-09-06 2008-04-02 杨水新 一种氟苯尼考微乳的制备方法
WO2008085310A2 (fr) * 2006-12-19 2008-07-17 Schering-Plough Ltd. Formulations effervescentes de florfénicol à ajouter dans les systèmes d'eau potable

Patent Citations (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004014340A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition injectable comprenant du florfenicol comme principe actif
WO2004014341A1 (fr) * 2002-08-13 2004-02-19 Dae Han New Pharm Co., Ltd. Composition pharmaceutique pour administration orale contenant du florfenicol en tant que principe actif
KR20050102309A (ko) * 2004-04-21 2005-10-26 대한뉴팜(주) 플로르페니콜을 유효성분으로 하는 주사제 조성물
WO2006067138A2 (fr) * 2004-12-21 2006-06-29 Intervet International B.V. Composition veterinaire injectable
KR20060105826A (ko) * 2005-04-04 2006-10-11 주식회사 고려비엔피 동물약품용 약제학적 조성물
WO2008085310A2 (fr) * 2006-12-19 2008-07-17 Schering-Plough Ltd. Formulations effervescentes de florfénicol à ajouter dans les systèmes d'eau potable
CN101152169A (zh) * 2007-09-06 2008-04-02 杨水新 一种氟苯尼考微乳的制备方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002497292, retrieved from STN Database accession no. 146:190 500 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002497293, retrieved from STN Database accession no. 145; 299 746 *
DATABASE CA [online] CHEMICAL ABSTRACTS SERVICE, COLUMBUS, OHIO, US; XP002549333, retrieved from STN Database accession no. 148: 456513 *

Also Published As

Publication number Publication date
FR2925335A1 (fr) 2009-06-26
WO2009083520A2 (fr) 2009-07-09
FR2925335B1 (fr) 2010-03-19

Similar Documents

Publication Publication Date Title
IL253038A0 (en) Preparations and methods for the treatment or prevention of infections. my voice
WO2011159839A3 (fr) Composés de thioacétate, compositions et procédés d'utilisation
TN2010000237A1 (en) Novel compounds and compositions and methods of use
MX2009003741A (es) Composiciones liquidas de calcogenuro y metodos para fabricar y utilizar las mismas.
WO2010135530A3 (fr) Composés, compositions et procédés pour moduler des taux d'acide urique
WO2011159840A3 (fr) Phénylthioacétates, compositions et procédés d'application
WO2007077561A3 (fr) Compositions et procédés permettant d'améliorer le captage in-vivo d'agents pharmaceutiques
CL2008000592A1 (es) Compuestos derivados de pirrol sustituido, supresores de la secrecion de acidos; composicion farmaceutica; y uso en el tratamiento o profilaxis en enfermedades tales como ulcera peptica, gastritis, esofagitis, entre otras.
EP2476461A3 (fr) Formulations pour le traitement du cancer
UA107582C2 (uk) Таблетований препарат (4'-трифторметилфеніл)аміду (z)-2-ціано-гідроксибут-2-еноєвої кислоти з поліпшеною стійкістю
MY162146A (en) Pharmaceutical composition
WO2009124871A3 (fr) Composition ayant une activité biocide pour les préparations aqueuses
WO2010028190A3 (fr) Composés, compositions, et procédés d'utilisation correspondants pour moduler des taux d'acide urique
WO2007125501A3 (fr) Compositions et procédés utiles pour le traitement d'une maladie respiratoire
WO2008122966A3 (fr) Composition pharmaceutique à base de tacrolimus
WO2009100277A3 (fr) Compositions et dispositifs
DK3486320T3 (da) Raav-guanylatcyklase-sammensætninger og fremgangsmåder til behandling af lebers kongenitte amaurose-1 (lca1)
EA201201324A1 (ru) Профилактика колоректального и желудочно-кишечного рака
BR112015008849A2 (pt) composições estáveis contendo perácido
WO2008112368A3 (fr) Agents de distribution d'acide phénylalkylcarboxylique
WO2010054286A3 (fr) Composés d'hydroxyphénylamine substitués
WO2008132021A3 (fr) Mélanges fongicides
ZA200905126B (en) Use of compounds of formula (i) and/or (II) for the preservation of human or animal bodies, and compositions containing the same
WO2009006246A8 (fr) Utilisation d'antagonistes des jonctions étanches pour traiter une plaie pulmonaire aiguë et le syndrome de détresse respiratoire aiguë
WO2009083520A3 (fr) Compositions orales liquides de florfenicol diluables dans l'eau de boisson

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 08868195

Country of ref document: EP

Kind code of ref document: A2

NENP Non-entry into the national phase

Ref country code: DE

122 Ep: pct application non-entry in european phase

Ref document number: 08868195

Country of ref document: EP

Kind code of ref document: A2